Caryn McDowell
Plus aucun poste en cours
Historique de carrière de Caryn McDowell
Anciens postes connus de Caryn McDowell
Sociétés | Poste | Début | Fin |
---|---|---|---|
QUINCE THERAPEUTICS, INC. | Directeur Administratif | 11/05/2020 | 08/07/2022 |
Conseiller Juridique Général | 11/05/2020 | 08/07/2022 | |
Secrétaire Général | 11/05/2020 | 08/07/2022 | |
CYTOKINETICS, INCORPORATED | Compliance Officer | 18/05/2016 | 01/05/2018 |
Conseiller Juridique Général | 01/05/2015 | 01/05/2018 | |
INTERMUNE INC | Corporate Officer/Principal | 01/01/2014 | 01/02/2015 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Conseiller Juridique Général | 01/06/2013 | 01/12/2013 |
AFFYMAX, INC. | Conseiller Juridique Général | 01/01/2012 | 01/01/2013 |
US Department of Health & Human Services (DC) | Corporate Officer/Principal | 01/01/2001 | 01/01/2004 |
REVANCE THERAPEUTICS, INC. | Conseiller Juridique Général | 01/05/2018 | - |
Secrétaire Général | 01/05/2018 | - | |
State of Massachusetts | Corporate Officer/Principal | - | - |
Formation de Caryn McDowell
University of Michigan | Undergraduate Degree |
Boston University School of Law | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
General Counsel | 5 |
Corporate Officer/Principal | 3 |
Corporate Secretary | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Government | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
AFFYMAX, INC. | Health Technology |
REVANCE THERAPEUTICS, INC. | Health Technology |
QUINCE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
US Department of Health & Human Services (DC) | Government |
State of Massachusetts | Government |
- Bourse
- Insiders
- Caryn McDowell
- Expérience